Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion

J Clin Gastroenterol. Nov-Dec 2015;49 Suppl 1:S69-73. doi: 10.1097/MCG.0000000000000420.

Abstract

This paper describes the consensus opinion of the participants in the 4th Triennial Yale/Harvard Workshop on Probiotic Recommendations. The recommendations update those of the first 3 meetings that were published in 2006, 2008, and 2011. Recommendations for the use of probiotics in necrotizing enterocolitis, childhood diarrhea, inflammatory bowel disease, irritable bowel syndrome and Clostridium difficile diarrhea are reviewed. In addition, we have added recommendations for liver disease for the first time. As in previous publications, the recommendations are given as A, B, or C ratings.

Publication types

  • Consensus Development Conference
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Child
  • Clostridium difficile
  • Diarrhea / microbiology
  • Diarrhea / therapy*
  • Enterocolitis, Necrotizing / microbiology
  • Enterocolitis, Necrotizing / therapy*
  • Enterocolitis, Pseudomembranous / microbiology
  • Enterocolitis, Pseudomembranous / therapy
  • Humans
  • Irritable Bowel Syndrome / microbiology
  • Irritable Bowel Syndrome / therapy*
  • Liver Diseases / microbiology
  • Liver Diseases / therapy*
  • Probiotics / standards*
  • Probiotics / therapeutic use